Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
about
Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia.Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors
P2860
Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Maternal plasma concentrations ...... restriction and preeclampsia.
@en
Maternal plasma concentrations ...... restriction and preeclampsia.
@nl
type
label
Maternal plasma concentrations ...... restriction and preeclampsia.
@en
Maternal plasma concentrations ...... restriction and preeclampsia.
@nl
prefLabel
Maternal plasma concentrations ...... restriction and preeclampsia.
@en
Maternal plasma concentrations ...... restriction and preeclampsia.
@nl
P2093
P2860
P50
P1476
Maternal plasma concentrations ...... h restriction and preeclampsia
@en
P2093
José Galaz
Laura Tuohey
Manarangi S De Silva
Ping Cannon
Sebastián E Illanes
Stephanie Acuña
P2860
P304
P356
10.1080/14767058.2016.1182975
P577
2016-05-16T00:00:00Z